[1] RIZVI S, KHAN SA, HALLEMEIER CL, et al.Cholangiocarcinoma-evolving concepts and therapeutic strategies[J].Nat Rev Clin Oncol, 2018, 15(2):95. doi: 10.1038/nrclinonc.2017.157
[2] PU LZ, SINGH R, LOONG CK.Malignant biliary obstruction:evidence for best practice[J].Gastroenterol Res Pract, 2016, 2016(11):1.
[3] SON RC, GWON DI, KO HK, et al.Percutaneous unilateral biliary metallic stent placement in patients with malignant obstruction of the biliary hila and contralateral portal vein steno-occlusion[J].Korean J Radiol, 2015, 16(3):586. doi: 10.3348/kjr.2015.16.3.586
[4] RAZUMILAVA N, GORES GJ.Classification, diagnosis, and management of cholangiocarcinoma[J].Clin Gastroenterol Hepatol, 2013, 11(1):13.
[5] LEWIS HL, RAHNEMAI-AZAR AA, DILLHOFF M, et al.Current management of perihilar cholangiocarcinoma and future perspectives[J].Chirurgia, 2017, 112(3):193. doi: 10.21614/chirurgia.112.3.193
[6] PARK K, KIM KP, PARK S, et al.Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer[J].Asia Pac J Clin Oncol, 2017, 13(1):13. doi: 10.1111/ajco.2017.13.issue-1
[7] JUN SY, SEOK YK, KATO T, et al.Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis[J].Obstet Gynecol Sci, 2017, 60(3):308. doi: 10.5468/ogs.2017.60.3.308
[8] MAURICE MJ, MADI R, CHUANG DY, et al.Retrograde chemoinfusion of the upper tract:standardizing the delivery of topical adjuvant therapy[J].J Endourol, 2013, 27(5):540. doi: 10.1089/end.2012.0608
[9] CEELEN W, VAN NIEUWENHOVE Y, PATTYN P.Surgery and intracavitary chemotherapy for peritoneal carcinomatosis from colorectal origin[J].Acta Gastroenterol Belg, 2008, 71(4):373.
[10] WESTPHAL M, LAMSZUS K, HILT D.Intracavitary chemotherapy for glioblastoma:present status and future directions[J].Acta Neurochir Suppl, 2003, 88:61. doi: 10.1007/978-3-7091-6090-9
[11] 马泰, 潘跃银, 孙国平, 等.恶性胸/腹腔积液病人腔内应用贝伐珠单抗的价值及疗效影响因素分析[J].中华疾病控制杂志, 2017(7):727.
[12] 于建全, 冯飞灵, 沈洋, 等.持续腹腔热灌注化疗治疗进展期胆管癌的临床疗效观察[J].第二军医大学学报, 2017, 38(5):570.
[13] SAVIER E, AZOULAY D, HUGUET E, et al.Percutaneous isolated hepatic perfusion for chemotherapy:a phase 1 study[J].Arch Surg, 2003, 138(3):325. doi: 10.1001/archsurg.138.3.325
[14] 黄伟, 刘会春, 王远鹏, 等.胆管癌病人腔内综合治疗与姑息性手术疗效比较[J].中华肝胆外科杂志, 2017, 23(6):289.
[15] 范恒伟, 刘会春, 李宗狂, 等.经PTCD途径胆道金属支架置入术治疗恶性梗阻性黄疸137例临床疗效分析[J].肝胆外科杂志, 2013, 21(2):94. doi: 10.3969/j.issn.1006-4761.2013.02.005
[16] 王勇, 刘会春, 李宗狂, 等.经皮胆道支架联合125I粒子腔内植入治疗恶性梗阻性黄疸的初步研究[J].中华放射学杂志, 2014, 48(5):403. doi: 10.3760/cma.j.issn.1005-1201.2014.05.011
[17] World Medical Association.World Medical Association Declaration of Helsinki:ethical principles for medical research involving human subjects[J].JAMA, 2013, 310(20):2191. doi: 10.1001/jama.2013.281053
[18] LABIB PL, DAVIDSON BR, SHARMA RA, et al.Locoregional therapies in cholangiocarcinoma[J].Hepat Oncol, 2017, 4(4):99. doi: 10.2217/hep-2017-0014
[19] SQUADRONI M, TONDULLI L, GATTA G, et al.Cholangiocarcinoma[J].Crit Rev Oncol Hematol, 2017, 116:11. doi: 10.1016/j.critrevonc.2016.11.012
[20] 金浩, 刘会春, 李宗狂, 等.肝门胆管癌103例诊治分析[J].蚌埠医学院学报, 2013, 38(11):1402.
[21] KOZAREK R.Role of preoperative palliation of jaundice in pancreatic cancer[J].J Hepatobiliary Pancreat Sci, 2013, 20(6):567. doi: 10.1007/s00534-013-0612-4
[22] HASIMU A, GU JP, JI WZ, et al.Comparative study of percutaneous transhepatic biliary stent placement with or without Iodine-125 seeds for treating patients with malignant biliary pbstruction[J].J Vasc Interv Radiol, 2017, 28(4):583. doi: 10.1016/j.jvir.2016.11.038
[23] 毛丽伟, 王阳, 廖国清, 等.腹腔热灌注化疗对晚期胃癌病人外周血和腹水调节性T细胞的影响及意义[J].检验医学与临床, 2016, 13(17):2429. doi: 10.3969/j.issn.1672-9455.2016.17.008
[24] 胡惠, 王宗鼎, 李可洲, 等.氟尿嘧啶联合丝裂霉素通过改变自噬作用抑制胆管癌细胞QBC939衰老并促进凋亡[J].第三军医大学学报, 2013, 35(18):1915.